
Jane J. Zara
Examiner (ID: 18595)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1674, 1637, 1635 |
| Total Applications | 1842 |
| Issued Applications | 1032 |
| Pending Applications | 285 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5159906
[patent_doc_number] => 20070172950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use of gene transfer'
[patent_app_type] => utility
[patent_app_number] => 11/728134
[patent_app_country] => US
[patent_app_date] => 2007-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 28167
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172950.pdf
[firstpage_image] =>[orig_patent_app_number] => 11728134
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/728134 | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use of gene transfer | Mar 22, 2007 | Abandoned |
Array
(
[id] => 91792
[patent_doc_number] => 07732207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Method for expression of small antiviral RNA molecules within a cell'
[patent_app_type] => utility
[patent_app_number] => 11/689407
[patent_app_country] => US
[patent_app_date] => 2007-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 14719
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732207.pdf
[firstpage_image] =>[orig_patent_app_number] => 11689407
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/689407 | Method for expression of small antiviral RNA molecules within a cell | Mar 20, 2007 | Issued |
Array
(
[id] => 111548
[patent_doc_number] => 07718432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Non-immunogenic, hydrophilic/cationic block copolymers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/725964
[patent_app_country] => US
[patent_app_date] => 2007-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12042
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718432.pdf
[firstpage_image] =>[orig_patent_app_number] => 11725964
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/725964 | Non-immunogenic, hydrophilic/cationic block copolymers and uses thereof | Mar 19, 2007 | Issued |
Array
(
[id] => 5533033
[patent_doc_number] => 20090232821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Use Of A Growth-Stimulating Protein'
[patent_app_type] => utility
[patent_app_number] => 12/225114
[patent_app_country] => US
[patent_app_date] => 2007-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11746
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232821.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225114
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225114 | Use Of A Growth-Stimulating Protein | Mar 13, 2007 | Abandoned |
Array
(
[id] => 4932907
[patent_doc_number] => 20080003682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'METHOD FOR EXPRESSION OF SMALL ANTIVIRAL RNA MOLECULES WITH REDUCED CYTOTOXICITY WITHIN A CELL'
[patent_app_type] => utility
[patent_app_number] => 11/683962
[patent_app_country] => US
[patent_app_date] => 2007-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22045
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003682.pdf
[firstpage_image] =>[orig_patent_app_number] => 11683962
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/683962 | Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell | Mar 7, 2007 | Issued |
Array
(
[id] => 5551802
[patent_doc_number] => 20090285788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'RANDOM RNAi LIBRARIES, METHODS OF GENERATING SAME, AND SCREENING METHODS UTILIZING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/281752
[patent_app_country] => US
[patent_app_date] => 2007-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 32059
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285788.pdf
[firstpage_image] =>[orig_patent_app_number] => 12281752
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/281752 | Random RNAi libraries, methods of generating same, and screening methods utilizing same | Mar 5, 2007 | Issued |
Array
(
[id] => 4658123
[patent_doc_number] => 20080026985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Control of gene expression'
[patent_app_type] => utility
[patent_app_number] => 11/712311
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19947
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026985.pdf
[firstpage_image] =>[orig_patent_app_number] => 11712311
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/712311 | Control of gene expression | Feb 27, 2007 | Abandoned |
Array
(
[id] => 5120579
[patent_doc_number] => 20070142294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade'
[patent_app_type] => utility
[patent_app_number] => 11/705672
[patent_app_country] => US
[patent_app_date] => 2007-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 33401
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142294.pdf
[firstpage_image] =>[orig_patent_app_number] => 11705672
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/705672 | Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade | Feb 12, 2007 | Issued |
Array
(
[id] => 5344619
[patent_doc_number] => 20090183269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'GENE EXPRESSION SYSTEM USING ALTERNATIVE SPLICING IN INSECTS'
[patent_app_type] => utility
[patent_app_number] => 12/278849
[patent_app_country] => US
[patent_app_date] => 2007-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 29123
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20090183269.pdf
[firstpage_image] =>[orig_patent_app_number] => 12278849
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278849 | GENE EXPRESSION SYSTEM USING ALTERNATIVE SPLICING IN INSECTS | Feb 11, 2007 | Abandoned |
Array
(
[id] => 7518499
[patent_doc_number] => 07972600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'IGF-IR antagonists as adjuvants for treatment of prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 11/702838
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11930
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/972/07972600.pdf
[firstpage_image] =>[orig_patent_app_number] => 11702838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/702838 | IGF-IR antagonists as adjuvants for treatment of prostate cancer | Feb 4, 2007 | Issued |
Array
(
[id] => 5199711
[patent_doc_number] => 20070299029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Hepatic stellate cell specific promoter and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/702018
[patent_app_country] => US
[patent_app_date] => 2007-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 17180
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299029.pdf
[firstpage_image] =>[orig_patent_app_number] => 11702018
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/702018 | Hepatic stellate cell specific promoter and uses thereof | Feb 1, 2007 | Abandoned |
Array
(
[id] => 5253259
[patent_doc_number] => 20070134715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT: BLENDED SELEX'
[patent_app_type] => utility
[patent_app_number] => 11/668337
[patent_app_country] => US
[patent_app_date] => 2007-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 8453
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134715.pdf
[firstpage_image] =>[orig_patent_app_number] => 11668337
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/668337 | SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT: BLENDED SELEX | Jan 28, 2007 | Abandoned |
Array
(
[id] => 4970747
[patent_doc_number] => 20070110749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Centrosome proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/656272
[patent_app_country] => US
[patent_app_date] => 2007-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 26049
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110749.pdf
[firstpage_image] =>[orig_patent_app_number] => 11656272
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/656272 | Centrosome proteins and uses thereof | Jan 21, 2007 | Abandoned |
Array
(
[id] => 6235342
[patent_doc_number] => 20100267046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'ISOFORM-SELECTIVE INHIBITOR AND ACTIVATORS OF PDE3 CYCLIC NUCLEOTIDE PHOSPHODIESTERASES'
[patent_app_type] => utility
[patent_app_number] => 11/654858
[patent_app_country] => US
[patent_app_date] => 2007-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 37169
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267046.pdf
[firstpage_image] =>[orig_patent_app_number] => 11654858
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/654858 | Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases | Jan 17, 2007 | Issued |
Array
(
[id] => 5236553
[patent_doc_number] => 20070128710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Novel protein associated with cell stress response'
[patent_app_type] => utility
[patent_app_number] => 11/654824
[patent_app_country] => US
[patent_app_date] => 2007-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14914
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128710.pdf
[firstpage_image] =>[orig_patent_app_number] => 11654824
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/654824 | Novel protein associated with cell stress response | Jan 17, 2007 | Abandoned |
Array
(
[id] => 4949892
[patent_doc_number] => 20080306018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Micro-Rna Expression Abnormalities of Pancreatic, Endocrine and Acinar Tumors'
[patent_app_type] => utility
[patent_app_number] => 12/160064
[patent_app_country] => US
[patent_app_date] => 2007-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 34426
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306018.pdf
[firstpage_image] =>[orig_patent_app_number] => 12160064
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/160064 | Micro-RNA expression abnormalities of pancreatic, endocrine and acinar tumors | Jan 2, 2007 | Issued |
Array
(
[id] => 5085871
[patent_doc_number] => 20070275922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 11/617899
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10559
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275922.pdf
[firstpage_image] =>[orig_patent_app_number] => 11617899
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/617899 | RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS | Dec 28, 2006 | Abandoned |
Array
(
[id] => 5120601
[patent_doc_number] => 20070142316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Antisense IAP oligonucleotides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/640405
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 16924
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142316.pdf
[firstpage_image] =>[orig_patent_app_number] => 11640405
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/640405 | Antisense IAP oligonucleotides and uses thereof | Dec 17, 2006 | Abandoned |
Array
(
[id] => 5259659
[patent_doc_number] => 20070213291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Therapeutically useful synthetic oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 11/641542
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18565
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213291.pdf
[firstpage_image] =>[orig_patent_app_number] => 11641542
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/641542 | Therapeutically useful synthetic oligonucleotides | Dec 17, 2006 | Abandoned |
Array
(
[id] => 5563692
[patent_doc_number] => 20090136544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Interfering RNAs Targeting the Morbillivirus Nucleoprotein Gene'
[patent_app_type] => utility
[patent_app_number] => 12/158620
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9792
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136544.pdf
[firstpage_image] =>[orig_patent_app_number] => 12158620
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/158620 | Interfering RNAs targeting the morbillivirus nucleoprotein gene | Dec 11, 2006 | Issued |